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Abstract 
In this paper, we propose a theoretical framework for software quality within the healthcare 
sector. The aim of this framework is to improve the quality of software produced within the 
healthcare and medical device industries, while assisting the manufacturers in achieving com-
pliance with existing regulation. To develop this framework, we undertook an evaluation of the 
healthcare and medical legislation. This was followed by an evaluation of existing software 
quality standards and models. The CMMI model was chosen as the model on which to base 
this framework. An initial mapping between CMMI and the US FDA Code of Federal Regula-
tions was undertaken. We present some of the examples the mapping here. 
Keywords 
CMMI, 21CFR820, medical software development, healthcare software development, software 
quality 
A Proposed Framework for Software 
Quality in the Healthcare and Medical 
Industry 
 
Vispi Shroff, Louise Reid, Ita Richardson 
Session I: will be adapted later by the editor 
2 − EuroSPI 2011 
 
1 Introduction 
One of the prominent issues in the software industry is the development of high-quality software [1]. 
When implementing software within the healthcare and medical industry the issues of software quality 
become more serious. As software in used increasingly within medical devices and in hospitals, any 
software quality issues can have significantly detrimental effects on a person’s recovery, health and 
well-being. Some of the earliest and most prominent cases were the Therac-25 accidents between 
1985 and 1987[2]. There is also a cost involved for organizations and companies when medical device 
recalls need to be made. Between 1999 and 2005, it was found that “one in every three medical de-
vices, making use of software for their operation, has been recalled due to failure in the software itself” 
[3]. 
Compliance with legislation is another major hurdle which companies have to overcome at present. 
Many companies are utilizing software development methodologies such as waterfall and V-model 
and are reticent to embrace agile methodologies. Having achieved certification and compliance many 
companies find the potential risk of failing compliance with regulation due to extensive changes in 
practices and processes to be an inhibiting factor in adopting new processes. 
In this paper, we have proposed a software quality framework which looks at software quality, soft-
ware standards, healthcare regulation and implementation within a software development life cycle 
which can facilitate continuous software process improvement. This framework has been proposed 
after carrying out a literature review and a study of existing practices in a clinical environment. It is 
developed within the context of implementation within a European healthcare system research project, 
the aim of which is to develop a “rapid learning healthcare system’ driven by advanced computational 
infrastructure that can improve both patient safety and the conduct and volume of clinical research in 
Europe” [4]. 
2 Research Methodology 
To develop an understanding of the domain, case study research was undertaken on a number of 
systems in an Irish Hospital. This provided an insight into the quality issues that are unique to the clin-
ical environment. This case study research was further strengthened by reviews into high profile hos-
pital investigations such as the Lourdes Hospital Inquiry [5], the Shipman Inquiry [6], the Tallaght Hos-
pital Review [7] and the investigation into the Therac 25 incidents.  Findings from our research pointed 
to the importance of quality processes to ensure the success of existing systems.  The Bristol enquiry 
found that the hospital was ‘awash with data but that there was very little information’; this sentiment 
was echoed in the Lourdes Hospital Enquiry. We found systems that are in place but underutilised. 
We found cases where the staff that should be making use of these systems did not trust them and 
that this led to loop of quality degeneration due to underuse of existing information. All of the investiga-
tions highlighted the fact that things can and do go wrong in the clinical environment but that the risk 
can be offset by robust quality processes.  
Through interviews with Irish medical device manufacturers and software vendors for the healthcare 
industry, we learnt that ensuring compliance with healthcare regulation can be a significant barrier to 
entry and a driver of effort and costs within the industry. A literature review was then carried out to 
study the current state of healthcare legislation.  The focus of this review was primarily on US and 
European legislation followed by a study of Irish regulation. Some issues around relevance and ambi-
guity were identified within the legislation. As increasing the quality of the products manufactured ap-
peared to be the purpose behind a lot of the regulation requirements, software quality standards and 
models such as the ISO 15504 and the various CMMI models were also studied.  
The initial research has focussed around creating a mapping between selected process areas within 
the CMMI model and the Code of Federal Regulations Title 21 Part 820 regulatory requirements. The 
aim of creating this mapping is to provide software vendors to the healthcare industry a set of software 
processes which when undertaken, may not only improve the quality of the software manufactured, 
but also assist them in becoming compliant with regulation. 
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2.1 Healthcare Legislation 
The US FDA Code of Federal Regulations was the core legislation studied. In particular, Subchapter H 
which focused on Medical Devices and Part 820 Quality System Regulation was studied in great depth 
[8]. This regulation is used as the foundation upon which the software quality models are mapped. 
European Council directives such as the Council Directive 90/385/EEC on Active Implantable Medical 
Devices (AIMDD), Council Directive 93/42/EEC on Medical Devices (MDD), Council Directive 
98/79/EC on In Vitro Diagnostic Medical Devices (IVDMD) and subsequent amendments via Council 
Directives 98/79/EC, 2000/70/EC, 2001/104/EC, 2003/32/EC and 2007/47/EC were also studied.  
Historically, the legislative requirements in the healthcare industry revolved around monitoring the 
processes and practices involved in the development of physical devices, not software. However, over 
the last couple of decades software has played a larger and increasingly significant role in the opera-
tion of medical devices. While the legislation was primarily developed to suit physical and hardware 
manufacturing processes, it has struggled to keep up with the changes in the manufacturing practices 
and the different problems and challenges which software development presents. 
The EU Council Directive 2007/47/EC has come closest to including standalone software into legisla-
tion by adding “Stand alone software is considered to be an active medical device” and “It is neces-
sary to clarify that software in its own right, when specifically intended by the manufacturer to be used 
for one or more of the medical purposes set out in the definition of a medical device, is a medical de-
vice. Software for general purposes when used in a healthcare setting is not a medical device” to the 
regulation. [9] 
 
Some of the other key issues we found within the medical legislation included 
• The lack of clear lines of distinction between hardware and software, and the impact of changes in 
software are not outlined. 
• The focus of the healthcare industry is on patient privacy and security with very little focus on in-
tegrity and accuracy. 
• Medical devices at present are categorized into three (US) or four (EU) different categories based 
on the potential impact they may have on patient health. These categories are shown in the table 
below, and there remains ambiguity in the definitions of these risk factors. 
Table 1. Risk-based Medical Device Categorization in Legislation 
EU Legislation US Legislation 
Class Risk Class Risk 
Class I Low Class I Low 
Class IIa Low-Medium Class II Medium 
Class IIb Medium-High Class III High 
Class III High   
 
Also, the proliferation of smartphones and the wide-spread usage of the application stores have seen 
a large increase in healthcare and medical applications becoming readily and openly available. At 
present, there is no means of implement and monitoring any regulatory or quality guidelines on these 
applications and this is becoming a major area of concern. 
2.1.1 Code of Federal Regulations Title 21Part 820 (21 CFR 820) 
As mentioned earlier, the 21CFR820 regulation document was adopted for the initial draft of the 
framework. To provide systems and solutions in the healthcare industry in the United States, products 
manufactured by companies need to be compliant with this regulation. The focus of this regulation is 
on the quality systems utilised in the manufacturing processes. There are certain artefacts which need 
to be created according to the 21CFR820 regulation. These artefacts are similar to and complement 
certain software engineering artefacts that are created as part of the software development lifecycle. 
Some examples of 21CFR820 artefacts include: 
• Design history file (DHF) means a compilation of records which describes the design history of a 
finished device. 
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• Device history record (DHR) means a compilation of records containing the production history of a 
finished device. 
• Device master record (DMR) means a compilation of records containing the procedures and 
specifications for a finished device. 
From the descriptions, we can see that these artefacts are similar to the requirements specifications, 
design documents and other material which may be created during the software development lifecy-
cle. So, if software development best practices are correctly followed, the creation of these artefacts 
and the documentation of the procedures and methods should take place, thereby assisting the soft-
ware vendor in achieving compliancy with the regulation. This is where recommendations by software 
quality standards and models can be of assistance in developing good software development practic-
es which assist a vendor in becoming compliant with regulation. 
2.2 CMMI 
For the purposes of this software quality framework, the Software Engineering Institute’s Capability 
Maturity Model Integrated (CMMI) for Development [10] was utilized. The CMMI model provides flexi-
bility as it allowed us to focus on very specific process areas. Also, this modularity would theoretically 
allow this framework to be implemented with any software development methodology. As the CMMI 
has its origins in Software Quality, and is freely and openly available it is widely adopted and validated 
by numerous companies and across various different industries. While it is heavily used in the soft-
ware industry, there are also case studies available on the implementation of CMMI in the health care 
services industry [11]. We also found that the CMMI model and its ability to measure capability and 
maturity of certain processes mapped very easily to the Quality and Risk Management Standard 
(QRMS) adopted by Irish Health Service Executive[12]. Apart from this, CMMI’s lays focus on and 
facilitates continuous SPI as compared to the IEC 62304 and other ISO standards. All these factors 
contributed towards the selection of CMMI as the primary model to base our framework on. 
To reduce the scope of the investigation, the six process areas within the CMMI were focused on for 
mapping to the 21CFR820 legislation. These included the process areas of Requirements Develop-
ment (RD), Requirements Management (REQM), Technical Solution (TS), Verification (VER) and Vali-
dation (VAL) and Configuration Management (CM). These process areas were chosen following dis-
cussions with the software developers and health informatics personnel involved in the healthcare 
system research project. These process areas were explored in depth and the specific practices and 
work products were mapped to the 21CFR820 legislation to see how they would satisfy regulatory 
requirements. 
3 The CMMI – 21CFR820 Mapping 
The fundamentals of the software quality framework lie in the mapping between the software models 
and the legislation. In the sections below, we have provided the mapping between the chosen process 
areas and how they satisfy different sections of the 21CFR820 legislation. Each process area within 
CMMI has a set of specific goals, each containing a set of specific practices. These specific practices 
are designed to assist in the accomplishment of the goal. The adoption of each of these specific prac-
tices creates certain outputs and deliverables. These outputs and deliverables can then be utilised to 
achieve compliancy with the existing regulations. 
 
We will illustrate this mapping using the specific goal of Analysing and Validating Requirements within 
the Requirements Development Process Area. 
3.1 Requirements Development Process Area 
The purpose of Requirements Development is to elicit, develop and analyse customer, product and 
product component requirements. It involves studying and understanding the customers need, expec-
tations and constraints which take into consideration all the stakeholder needs. Customer require-
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ments are further developed into product requirements and product component requirements which 
are consistent with customer requirements.  
CMMI provides three specific goals; develop customer requirements, develop product requirements 
and to analyse and validate requirements. The latter goal of validating and analysing the requirements 
is designed to assist in the accomplishment of the former two goals.  
 
An example of this mapping, the CMMI-21CFR820 mapping is shown in the table below. 
Table 2. Analyze and Validate Requirements 
No. Specific Practice Deliverables Legislation 
SP 3.1 Establish operational con-
cepts and scenarios 
Operational concepts of the systems DMR 
SP 3.1 Establish operational con-
cepts and scenarios 
Product or product component installation, 
operational, maintenance and support con-
cepts 
DMR 
SP 3.1 Establish operational con-
cepts and scenarios 
Disposal concepts DMR 
SP 3.1 Establish operational con-
cepts and scenarios 
Use Cases DMR 
SP 3.1 Establish operational con-
cepts and scenarios 
Timeline scenarios DMR 
SP 3.1 Establish operational con-
cepts and scenarios 
New requirements DMR 
SP 3.2 Establish a definition of re-
quired functionality 
Functional Architecture DMR 
SP 3.2 Establish a definition of re-
quired functionality 
Activity diagrams, use cases DMR 
SP 3.2 Establish a definition of re-
quired functionality 
Object oriented analysis; services and 
methods defined 
DMR 
SP 3.3 Analyse Requirements Key Requirements DMR 
SP 3.3 Analyse Requirements Technical performance measures to meas-
ure progress 
DMR 
SP 3.3 Analyse Requirements Requirements defects reports DMR 
SP 3.3 Analyse Requirements Proposed Requirements Defects Reports DMR 
SP 3.4 Analyse Requirements to 
Achieve Balance 
Document assessing risks related to re-
quirements defined 
21CFR820 
Sec 820.30 
SP 3.5 Validate Requirements Records of requirements validation analy-
sis and results 
21CFR820 
Sec 820.65 
SP 3.5 Validate Requirements Change reports for requirements which 
need changes based on validation results. 
21CFR820 
Sec 820.65 
In this case, when following the specific practices for achieving the Requirements Development goal of 
analysing and validating requirements, the software manufacturer may create use cases, timeline 
scenarios, a functional architecture and much more. Many of these artefacts can be then be utilised in 
the creation of the Device Master Record (DMR) of the software for compliance with 21CFR820. 
4 Future Research 
There is great scope for future research to enhance the framework. The key challenges at present lie 
in addressing the applicability of such a framework within industry. We will be using the healthcare 
system research project as a test bed to evaluate the applicability of such a framework within software 
development teams. For evaluation purposes, it will be necessary to utilize a software development 
methodology to implement the framework.  
Other areas of research would include extending the framework to include European legislation pri-
marily, and other regional legislation may follow. European and US legislation tend to be leading the 
world as far as healthcare and medical devices are concerned, encompassing these bodies of legisla-
tion should lead to a framework which relatively encompasses universal legislation. 
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After extending the framework to include other legislation, one may look at other software quality 
models and standards such as the ISO standards to enhance aspects which may be missing from this 
model. For example, when compared to IEC 62304, CMMI was found “lacking specific safety related 
requirements that have been derived over time though regulatory monitoring of software intensive 
medical devices.”[13] 
Finally, due to the intensive nature of the quality framework, as well as the amount of regulation in-
volved, it would be worthwhile creating different models of the framework based on risk assessment of 
the medical device of software being produced. If a software or medical device is evaluated to be a 
low risk device, i.e. Class I device, then it may not be necessary to follow all the recommendations 
within the framework. In such situations, it might be worthwhile having a model of the framework which 
is designed for the different classes of risk. However, interviews with medical device manufacturers 
have shown us that the default class assumed by regulators is the highest risk class, and the onus lies 
on the manufacturers to demonstrate the reduced risk. Also, even though individual components may 
be fall under a lower risk category, the final evaluation is based on the overall risk classification of the 
medical device or software. So, even though software may play a miniscule and trivial role in the over-
all functioning of a medical device, if that medical device is classified as a Class III device, the soft-
ware will need to pass Class III regulation guidelines. 
Finally, one of the prominent issues which arose during the investigation into the case studies and 
subsequent interviews with hospital clinicians was that many hospital systems remained underused or 
stagnant due to the lack of trust in the systems and the general sentiment that the systems were not 
‘fit-for-purpose‘. After the framework has been developed in further depth, the study of software devel-
opment lifecycles may be carried out with a particular focus on agile processes. Within the European 
healthcare system research project, the Scrum methodology was proposed for implementation and will 
be observed for effectiveness against the scale and the nature of the project. We will also observe 
how the Scrum methodology facilitates this framework with the least challenges while allowing modifi-
cation and improvement of the framework over time. 
 
5 Conclusion 
We have laid the foundations for a software quality framework for the healthcare and medical device 
industry. In a world where software is playing an increasingly pivotal role in the delivery of healthcare 
and patient well-being, the quality of the software being used is paramount. While there has been ex-
tensive work done on the patient privacy and data security side of the spectrum, there has been little 
focus on the data integrity and accuracy within systems which are becoming increasingly integrated. In 
this framework, our focus has not been on the outputs of the software development processes, but 
rather on the software development processes themselves. The proposed framework provides flexibil-
ity as a single component of it can be used by itself, or it can be implemented in its entirety. As the 
medical and healthcare industry is a heavily regulated industry, an equal amount of focus was laid on 
the existing legislation. It is the authors’ goal to provide a framework which is flexible, practical and 
easily implementable. We believe this framework allows the manufacturers to be compliant with regu-
lation while developing high quality software. 
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